Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study-Reference-Cited by-同舟云学术

Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study

Published:2005-03-01 Issue:3 Volume:20 Page:629-635
ISSN:1460-2350
Container-title:Human Reproduction
language:en
Short-container-title:

Author:

Hugues J.N.,Soussis J.,Calderon I.,Balasch J.,Anderson R.A.,Romeu A.

Publisher

Oxford University Press (OUP)

Subject

Obstetrics and Gynecology,Rehabilitation,Reproductive Medicine

Link

http://academic.oup.com/humrep/article-pdf/20/3/629/6953233/deh682.pdf

Reference31 articles.

1. Balasch J and Fábregues F (2003) Pregnancy after administration of high dose recombinant human LH alone to support final stages of follicular maturation in a woman with long-standing hypogonadotrophic hypogonadism. Reprod Biomed Online6, 427–431.

2. Balasch J, Miro F, Burzaco I, Casamitjana R, Civico S, Ballesca JL, Puerto B and Vanrell JA (1995) The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant follicle stimulating hormone. Hum Reprod10, 1678–1683.

3. Brown JB (1978) Pituitary control of ovarian function—concepts derived from gonadotrophin therapy. Aust NZ J Obstet Gynaecol18, 47–55.

4. Buvat J, Buvat-Herbaut M, Marcolin G, Dehaene JL, Verbecq P and Renouard O (1989) Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective. Fertil Steril52, 553–559.

5. Chappel SC and Howles C (1991) Re-evaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod6, 1206–1212.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letrozole co-treatment in an antagonist protocol for overweight women undergoing IVF treatment: a retrospective study;BMC Pregnancy and Childbirth;2024-09-10

2. The Efficacy of Letrozole Co-Treatment in an Antagonist Protocol for Women with Polycystic Ovary Syndrome Undergoing IVF: A Retrospective Study;Drug Design, Development and Therapy;2024-07

3. Letrozole cotreatment improves the follicular output rate in high-body-mass-index women with polycystic ovary syndrome undergoing IVF treatment;Frontiers in Endocrinology;2023-03-03

4. A Narrative Review Discussing the Efficiency of Personalized Dosing Algorithm of Follitropin Delta for Ovarian Stimulation and the Reproductive and Clinical Outcomes;Diagnostics;2023-01-04

5. Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment;Frontiers in Physiology;2022-08-19